TransMedics targets up to $605M 2025 revenue as international expansion accelerates
Earnings Call Insights: TransMedics Group, Inc. (TMDX) Q3 2025 Management View Waleed Hassanein, Founder, President, CEO & Director, emphasized the company's position in the global organ transplantation market, noting, “Globally, TransMedics is uniquely...
Seeking Alpha